GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care
Send a textThis week on On The Pen, we break down a rare FDA walk-back on GLP-1 safety labeling, major pharma signals coming out of JPM 2026, and the growing tension between patient access and legisla...
13 Tammi 27min
Wegovy Pens Recalled & Wegovy Pill Launch
Send a textThis episode opens the year with one of the most consequential—and complicated—weeks in GLP-1 obesity medicine.We break down three stories that, taken together, reveal why patients are incr...
6 Tammi 26min
Wegovy Pill Approved: First Ever GLP-1 Pill, As Good as Injections!
Send a texthttps://www.OTPLinks.com🤝 Visit Our Sponsors!OTPLinks.com Decoding GLP-1 BookDecoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4MY WORK RELI...
23 Joulu 202529min
GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
Send a textPharma Influence & Why Patient Voices MatterLobbying Power: Eli Lilly, Novo Nordisk, and Government AccessWhy GLP-1 Medication Access Is at RiskIntroducing Sabina Hemi & the Mission of GLP ...
19 Joulu 202559min
Compounded Retatrutide? What the Judge Said
Send a textRetatrutide is years away from FDA approval and yet the fight over access, price, control of this medication is already well underway. That's what this podcast is going to be about today. T...
16 Joulu 202529min
Retatrutide Weight Loss: How Much At Each Dose
Send a texthttps://www.otplinks.com0:00 Welcome & today’s focus: Retatrutide and “chasing the biggest number”1:11 On The Pen intro, live schedule (Mon/Wed/Fri) & housekeeping2:10 How Dave first heard ...
13 Joulu 202550min
Mounjaro vs. New Obesity Drugs: Why Wave-007 Is Stealing the Spotlight
Send a textEpisode Timeline & Main Topics00:00 — Opening & Community Update• First week doing the podcast fully live thanks to the On The Pen community• Overview of why this week’s news is a major tur...
9 Joulu 202534min
GLP-1: New Metrics, New Molecules, New Prices
Send a textTopics We Cover:00:00 – New data from Harvard/Mass General may classify nearly 70% of adults as having obesity03:00 – A new oral triple agonist shows record-setting absorption rates07:00 – ...
2 Joulu 202529min
